Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Trends in Immunology   Volumes    Volume 23 
HIV and diabetes: Is there a possibility of immune function and inflammation manipulation using lncRNAs as a therapeutic agent in the pre-diabetic state?
N. C. Mzimela, T. Zondi, S. Sibiya, A. Khathi
Pages: 125 - 135
Number of pages: 11
Current Trends in Immunology
Volume 23 

Copyright © 2022 Research Trends. All rights reserved

Studies show that some people are living with undiagnosed pre-diabetes while also carrying the human immunodeficiency virus (HIV). Pre-diabetes is a state of intermediate hyperglycaemia that often precedes the onset of type 2 diabetes. HIV has been reported to affect the immune system as well as the secretion of cytokines involved in the inflammatory response. At this stage it is still a debatable issue if all the abnormalities observed in type 2 diabetes develop during pre-diabetes. However, the coexistence of diabetes and HIV can exacerbate chronic inflammation and could further compromise the immune system. Reports have shown that the long noncoding RNAs are expressed by various immune cells upon immune activation. This then gave rise to the idea of using long noncoding RNAs as therapeutic agents to improve the immune system. Therefore, this review sought to explore if long noncoding RNAs could be a possible solution to the increased inflammation at a genetic level during pre-diabetes in HIV-positive patients.
Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms